Lim B - Search Results

1

Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy.

Masuda H, Harano K, Miura S, Wang Y, Hirota Y, Harada O, Jolly MK, Matsunaga Y, Lim B, Wood AL, Parinyanitikul N, Jin Lee H, Gong G, George JT, Levine H, Lee J, Wang X, Lucci A, Rao A, Schweitzer BL, Lawrence OR, Seitz RS, Morris SW, Hout DR, Nakamura S, Krishnamurthy S, Ueno NT. Masuda H, et al. Among authors: lim b. JCO Precis Oncol. 2022 Mar;6:e2000368. doi: 10.1200/PO.20.00368. JCO Precis Oncol. 2022. PMID: 35294223 Free PMC article.

2

Two histopathologically different diseases: hormone receptor-positive and hormone receptor-negative tumors in HER2-positive breast cancer.

Lee HJ, Park IA, Park SY, Seo AN, Lim B, Chai Y, Song IH, Kim NE, Kim JY, Yu JH, Ahn JH, Gong G. Lee HJ, et al. Among authors: lim b. Breast Cancer Res Treat. 2014 Jun;145(3):615-23. doi: 10.1007/s10549-014-2983-x. Epub 2014 May 13. Breast Cancer Res Treat. 2014. PMID: 24820412

3

Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy.

Lee HJ, Song IH, Seo AN, Lim B, Kim JY, Lee JJ, Park IA, Shin J, Yu JH, Ahn JH, Gong G. Lee HJ, et al. Among authors: lim b. Ann Surg Oncol. 2015 Feb;22(2):392-400. doi: 10.1245/s10434-014-4054-2. Epub 2014 Sep 6. Ann Surg Oncol. 2015. PMID: 25192679

4

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?

Le Du F, Eckhardt BL, Lim B, Litton JK, Moulder S, Meric-Bernstam F, Gonzalez-Angulo AM, Ueno NT. Le Du F, et al. Among authors: lim b. Oncotarget. 2015 May 30;6(15):12890-908. doi: 10.18632/oncotarget.3849. Oncotarget. 2015. PMID: 25973541 Free PMC article. Review.

5

Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer.

Lee J, Galloway R, Grandjean G, Jacob J, Humphries J, Bartholomeusz C, Goodstal S, Lim B, Bartholomeusz G, Ueno NT, Rao A. Lee J, et al. Among authors: lim b. J Cancer. 2015 Oct 28;6(12):1306-19. doi: 10.7150/jca.13266. eCollection 2015. J Cancer. 2015. PMID: 26640591 Free PMC article.

6

Identification of frequent somatic mutations in inflammatory breast cancer.

Matsuda N, Lim B, Wang Y, Krishnamurthy S, Woodward W, Alvarez RH, Lucci A, Valero V, Reuben JM, Meric-Bernstam F, Ueno NT. Matsuda N, et al. Among authors: lim b. Breast Cancer Res Treat. 2017 Jun;163(2):263-272. doi: 10.1007/s10549-017-4165-0. Epub 2017 Feb 27. Breast Cancer Res Treat. 2017. PMID: 28243898

7

Early clinical development of epidermal growth factor receptor targeted therapy in breast cancer.

Matsuda N, Lim B, Wang X, Ueno NT. Matsuda N, et al. Among authors: lim b. Expert Opin Investig Drugs. 2017 Apr;26(4):463-479. doi: 10.1080/13543784.2017.1299707. Epub 2017 Mar 8. Expert Opin Investig Drugs. 2017. PMID: 28271910 Free PMC article. Review.

8

Androgen Receptor Function and Androgen Receptor-Targeted Therapies in Breast Cancer: A Review.

Kono M, Fujii T, Lim B, Karuturi MS, Tripathy D, Ueno NT. Kono M, et al. Among authors: lim b. JAMA Oncol. 2017 Sep 1;3(9):1266-1273. doi: 10.1001/jamaoncol.2016.4975. JAMA Oncol. 2017. PMID: 28301631 Review.

9

Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging system.

Fouad TM, Barrera AMG, Reuben JM, Lucci A, Woodward WA, Stauder MC, Lim B, DeSnyder SM, Arun B, Gildy B, Valero V, Hortobagyi GN, Ueno NT. Fouad TM, et al. Among authors: lim b. Lancet Oncol. 2017 Apr;18(4):e228-e232. doi: 10.1016/S1470-2045(17)30192-4. Lancet Oncol. 2017. PMID: 28368261 Free PMC article. Review.

10

Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.

Torres-Adorno AM, Lee J, Kogawa T, Ordentlich P, Tripathy D, Lim B, Ueno NT. Torres-Adorno AM, et al. Among authors: lim b. Clin Cancer Res. 2017 Aug 15;23(16):4780-4792. doi: 10.1158/1078-0432.CCR-16-2622. Epub 2017 May 2. Clin Cancer Res. 2017. PMID: 28465444 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,624 results

Search Page